Company News

Nanalysis Scientific Corp. ("the Company", TSXV: NSCI OTCQX: NSCIF FRA: 1N1 ), a leader in portable MRI and NMR machines for healthcare and industrial applications, announced quarterly preliminary revenue of $4.4 million in Q2 of 2021, a 120% increase over Q2 2020.

While the company is not reporting full financials until the middle of August, CFO, Luke Caplette states: "We wanted to release our top line numbers to highlight our exciting growth and strengthening company fundamentals. We are continuing to see strong results from our efforts in 2020. The team did a remarkable job on all levels to achieve this level of growth. We demonstrated positive EBITDA in Q1 2021, and our cost structure has remained relatively unchanged. As a result, we expect solid profitability on an EBITDA basis when we release our full Q2 financials".

CEO, Sean Krakiwsky states "We showed over 115% revenue growth in Q1, and again now with 120% growth in Q2 as compared to the same quarter in the prior year. These results show that we remain on this growth trajectory."

"The benefits of our first acquisition are clearly showing on the top line and also as a technology tuck-in with the integration of the new electronics platform into our 100 MHz product. Fueled by increasing production of our 100 MHz product, continued growth in 60 MHz sales, as well as sales related to our MRI and NMR electronics modules, we are very optimistic about 2021 and beyond."

Mr. Krakiwsky continued: "We will continue to combine strong organic growth with new, complementary acquisitions in magnetic resonance that are accretive and of medium and long-term strategic importance."

The financial disclosure in this release is unaudited and could be subject to revision when the company releases its financial statements for the quarter.

About Nanalysis Scientific Corp. ( TSXV: NSCI , OTCQX: NSCIF, FRA:1N1)

Nanalysis is listed  on the TSX Venture Exchange (TSXV) in Canada with ticker symbol ' NSCI ' ,Over the Counter (OTC) in the United States under the ticker symbol ' NSCIF ', and on the Frankfurt Exchange (FRA) under the symbol ' 1N1 '.

Nanalysis is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D).

Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Its advanced 60 and 100 MHz spectrometers require no liquid helium or other cryogens. These devices are used by chemical professionals spanning a wide variety of industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology.

Through its European subsidiary RS2D, the Company's electronic boards and software are used in conventional NMR and MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices.

To sign up for updates relating to Nanalysis, please complete the online form found HERE .

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE Nanalysis Scientific Corp.

Cision View original content: http://www.newswire.ca/en/releases/archive/July2021/13/c8091.html

News Provided by Canada Newswire via QuoteMedia

Tantalus Systems Holding Inc. Reports Financial Results for Q2 of 2022

Tantalus Systems Holding Inc. Reports Financial Results for Q2 of 2022

Tantalus Systems (TSX: GRID) ("Tantalus" or the "Company"), a smart grid technology company focused on helping build sustainable utilities for the future, is pleased to announce its financial and operating results for the second quarter ended June 30, 2022.

"We are pleased with the progress our team continues to make in 2022 despite operating in a challenging business environment. In addition to delivering revenue growth of approximately 13% in the quarter as compared to last year, we also had 5 new utilities join our user community during Q2," stated Peter Londa, President & CEO of Tantalus. "In addition to expanding our user community, we delivered a new milestone for converted orders from our sales pipeline for the first six months of a calendar year at $24.7 million, reflecting 44% growth year-over-year. We also set a new high-water mark for our Annualized Recurring Revenue1 which now stands at $9.0 million."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Greenlane Renewables Announces Second Quarter 2022 Financial Results

Greenlane Renewables Announces Second Quarter 2022 Financial Results

~Company reports record revenue with consistent gross margins~

 Greenlane Renewables Inc. (" Greenlane '' or the " Company ") (TSX: GRN) (FSE: 52G) (OTC: GRNWF) today announced financial results for the second quarter ended June 30, 2022 . For further information on these results please see the Company's Condensed Consolidated Interim Financial Statements and Management's Discussion and Analysis filed under the Company's profile on SEDAR at www.sedar.com . All amounts are in Canadian dollars unless otherwise stated and in accordance with International Financial Reporting Standards (" IFRS ").

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
dynaCERT Announces Auditor Resignation

dynaCERT Announces Auditor Resignation

dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (" dynaCERT " or the "Company") announces the resignation of its auditors, BDO Canada LLP ("BDO"). BDO resigned on their own initiative, which resignation has been reviewed by dynaCERT 's audit committee. BDO has advised that its resignation is a business decision of such firm and has confirmed that there are no reportable events, "disagreements" or "unresolved issues" (as those terms are defined in National Instrument 51-102 Continuous Disclosure Obligations ) in connection with the change of auditor. dynaCERT is commencing the process to engage a replacement auditor for the 2022 fiscal year.

About dynaCERT Inc.
dyna CERT Inc. manufactures and distributes Carbon Emission Reduction Technology for use with internal combustion engines. As part of the growing global hydrogen economy, our patented technology creates hydrogen and oxygen on-demand through a unique electrolysis system and supplies these gases through the air intake to enhance combustion, resulting in lower carbon emissions and greater fuel efficiency. Our technology is designed for use with many types and sizes of diesel engines used in on-road vehicles, refrigerated trailers, off-road construction, power generation, mining and forestry equipment, marine vessels and railroad locomotives. Website: www.dynaCERT.com .

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Nano One Provides Quarterly Progress Update and Reports Q2 2022 Results

Nano One Provides Quarterly Progress Update and Reports Q2 2022 Results

TSX:NANO) (OTC PINK:NNOMF) (Frankfurt:LBMB

nano one® Materials Corp. ("nano one" or the "Company") is a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries. nano one has filed its unaudited condensed interim consolidated financial statements (the "financial statements") and management's discussion & analysis for the second fiscal quarter ended June 30, 2022 and is pleased to provide the following highlights from Q2 2022.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
BriaCell Secures License for a Promising Novel Anti-Cancer Agent

BriaCell Secures License for a Promising Novel Anti-Cancer Agent

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that it has secured an exclusive license from University of Maryland, Baltimore County (UMBC) to develop and commercialize Soluble CD80 (sCD80) as a biologic agent for the treatment of cancer.

The novel technology, originally developed by Suzanne Ostrand-Rosenberg, Ph.D., Emeritus Faculty at UMBC, and member of BriaCell's scientific advisory board, is titled "Soluble CD80 as a Therapeutic to Reverse Immune Suppression in Cancer Patients" and covered under USPN 8,956,619 B2 , USPN 9,650,429 B2 , and USPN 10,377,810 B2 . In animal models, sCD80 was well-tolerated and stopped tumor growth by potentially restoring natural anti-tumor immunity (see Lucas A Horn, et al . and Samuel T Haile et al. in collaboration with Dr. Ostrand-Rosenberg). Additionally, strong anti-tumor activity of sCD80 has been reported in multiple tumor types (see Lucas A Horn, et al .). Importantly, as demonstrated in the same studies, sCD80's unique actions may involve both awakening and boosting the immune system to recognize and destroy tumor cells.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
DGTL Holdings Inc. Reports Four New PaaS Contracts from Leading CPG Brands

DGTL Holdings Inc. Reports Four New PaaS Contracts from Leading CPG Brands

Four Brands from Two Global CPG Conglomerates Leverage Patented Data and Analytics PaaS for Analysis of Digital Advertising Sponsorships During Top Broadcasted Sporting Event in North America

DGTL Holdings Inc. (TSXV: DGTL) ("DGTL" or the "Company") is pleased to announce that its wholly owned subsidiary Engagement Labs has secured four new PaaS (Platform-as-a-Service) contracts from two global consumer packaged goods (CPG) conglomerates.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×